Advertisement
Home 2016

Archives

An experimental DNA-based vaccine for Zika virus has proceeded to human safety trials

Animal Study Finds DNA-Based Vaccine Effective Against Zika

0
Human safety trials are already under way, researchers add
Falls are the leading cause of injury and death among older people in the United States

CDC: Falls Leading Cause of Injury, Death in U.S. Seniors

0
Falls cause millions of injuries and soaring health care costs, CDC report shows
For asymptomatic patients with type 2 diabetes

CCTA Has Prognostic Value in Asymptomatic T2DM Patients

0
Excellent long-term prognoses for patients with normal coronary arteries, non-obstructive CAD
Among children with persistent asthma

High Prevalence of Allergic Sensitization in Pediatric Asthma

0
Microarray methods provide new information in 47 percent of sensitized children
For patients with type 1 diabetes

Decline in eGFR Mainly Linear in Type 1 Diabetes

0
Trajectories in eGRF decline were linear for about 87 percent of patients, accelerating for 6 percent
Congenital brain abnormalities are similar for confirmed and presumed Zika infections

Findings to Help Radiologists ID Zika Virus Infection at Imaging

0
Similar brain abnormalities seen in confirmed and presumed congenital Zika infections
In obese patients

Changes in Blood Microbiota in Obese With Liver Fibrosis

0
Among obese patients, 16S rDNA concentration significantly higher for those with liver fibrosis
For preterm infants with early respiratory distress

Tx Failure Up for High-Flow Therapy Versus CPAP in Preemies

0
Significantly higher rate of treatment failure than CPAP in preterm infants with respiratory distress
For adults with acute Plasmodium vivax or P. falciparum

KAF156 Active for Adults With Vivax, Falciparum Malaria

0
Antimalarial activity seen with multiple and single dose, with no serious adverse events
A new type of immunotherapy involving natural killer cells may help treat acute myeloid leukemia patients

Immunotherapy Promising for Tx of Acute Myeloid Leukemia

0
In preliminary trial, four of nine patients with acute myeloid leukemia had complete remission